Dr. Neil B. Newman, MD

Dr. Newman practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Newman's NPI, 1740642081, was assigned on March 25, 2016. Dr. Newman graduated from Rutgers Robert Wood Johnson Medical School in 2016. Dr. Newman holds Texas license T1486.

Dr. Newman's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Newman's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Newman is also affiliated with University Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Newman to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Newman practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Newman's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Newman is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Newman's licenses on file in 2 states: Texas and New Jersey.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, lung cancer radiation, lymphoma radiation and pancreatic cancer radiation among the conditions Dr. Newman treats.

CMS data shows 2,520 Medicare services from Dr. Newman across 17 procedure codes in 2024, for 109 Medicare patients. Medicare paid $263,378 for them. Every service was in an office.

CMS counts 109 Medicare patients who saw Dr. Newman in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Newman's median patient age at 74, with 49% women.

In 2024, Dr. Newman wrote 126 Medicare Part D claims for 39 patients. 94% of them were for generic drugs. CMS names the drug for 48 of them, across 2 drugs with 11 or more claims each, at $213 in total drug cost. In 2023, CMS named 45 claims across 2 drugs.

Dr. Newman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Newman as offering telehealth.

Dmand AI links 43 papers to Dr. Newman, published from 2015 to 2025. 2019 was the busiest year, with 7. The most frequent topics are Liver Neoplasms, Carcinoma, Hepatocellular and Antineoplastic Combined Chemotherapy Protocols. Dr. Newman has published most often in Int J Radiat Oncol Biol Phys. Dr. Newman's most frequent co-authors are Evan Charles Osmundson, MD, PhD, Alexander Dean Sherry, MD and Salma K. Jabbour.

CMS Open Payments shows 6 general payments to Dr. Newman from 5 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Novocure Inc. paid the most, $275.

Dr. Newman graduated from Rutgers Robert Wood Johnson Medical School in 2016.

Dr. Newman is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.